Last reviewed · How we verify
Keytruda — drug interactions
Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response.
Contraindications
- Known hypersensitivity to berahyaluronidase alfa
- Known hypersensitivity to hyaluronidase
- Known hypersensitivity to any excipients
See also
- Full profile: Keytruda
- Side effects: /side-effects
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Cost & pricing: /cost
- Clinical trials: /clinical-trials
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing